These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

7810 related items for PubMed ID: 1906286

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin.
    Rosenblum MG, Marks JW, Cheung LH.
    Cancer Chemother Pharmacol; 1999; 44(4):343-8. PubMed ID: 10447583
    [Abstract] [Full Text] [Related]

  • 4. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
    Scott CF, Goldmacher VS, Lambert JM, Jackson JV, McIntyre GD.
    J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
    [Abstract] [Full Text] [Related]

  • 5. Cellular resistance to the antimelanoma immunotoxin ZME-gelonin and strategies to target resistant cells.
    Rosenblum MG, Cheung L, Kim SK, Mujoo K, Donato NJ, Murray JL.
    Cancer Immunol Immunother; 1996 Feb; 42(2):115-21. PubMed ID: 8620520
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin.
    Mujoo K, Cheung L, Murray JL, Rosenblum MG.
    Cancer Immunol Immunother; 1995 May; 40(5):339-45. PubMed ID: 7600567
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
    Wawrzynczak EJ, Cumber AJ, Henry RV, May J, Newell DR, Parnell GD, Worrell NR, Forrester JA.
    Cancer Res; 1990 Dec 01; 50(23):7519-26. PubMed ID: 2253201
    [Abstract] [Full Text] [Related]

  • 9. Antibody-mediated delivery of tumor necrosis factor (TNF-alpha): improvement of cytotoxicity and reduction of cellular resistance.
    Rosenblum MG, Cheung L, Murray JL, Bartholomew R.
    Cancer Commun; 1991 Jan 01; 3(1):21-7. PubMed ID: 1989645
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody.
    Hirota N, Ueda M, Ozawa S, Abe O, Shimizu N.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7106-9. PubMed ID: 2555059
    [Abstract] [Full Text] [Related]

  • 12. Potentiation of antiproliferative effects of monoclonal antibody Lym-1 and immunoconjugate Lym-1-gelonin on human Burkitt's lymphoma cells with gamma-interferon and tumor necrosis factor.
    O'Boyle KP, Colletti D, Mazurek C, Wang Y, Ray SK, Diamond B, Rosenblum MG, Epstein AL, Shochat D, Dutcher JP.
    J Immunother Emphasis Tumor Immunol; 1995 Nov 15; 18(4):221-30. PubMed ID: 8680650
    [Abstract] [Full Text] [Related]

  • 13. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
    Wiels J, Junqua S, Dujardin P, Le Pecq JB, Tursz T.
    Cancer Res; 1984 Jan 15; 44(1):129-33. PubMed ID: 6690030
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
    Cazzola M, Bergamaschi G, Dezza L, D'Uva R, Ponchio L, Rosti V, Ascari E.
    Cancer Res; 1991 Jan 15; 51(2):536-41. PubMed ID: 1985771
    [Abstract] [Full Text] [Related]

  • 15. A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2.
    Mujoo K, Reisfeld RA, Cheung L, Rosenblum MG.
    Cancer Immunol Immunother; 1991 Jan 15; 34(3):198-204. PubMed ID: 1756537
    [Abstract] [Full Text] [Related]

  • 16. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE, Brown AN, Bremner JA, Foxwell BM, Stirpe F.
    J Natl Cancer Inst; 1985 Jul 15; 75(1):151-9. PubMed ID: 3859688
    [Abstract] [Full Text] [Related]

  • 17. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S, Houston LL.
    Cancer Res; 1984 Apr 15; 44(4):1398-404. PubMed ID: 6142765
    [Abstract] [Full Text] [Related]

  • 18. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
    Masui H, Kamrath H, Apell G, Houston LL, Mendelsohn J.
    Cancer Res; 1989 Jul 01; 49(13):3482-8. PubMed ID: 2786451
    [Abstract] [Full Text] [Related]

  • 19. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
    Gridley DS, Slater JM, Stickney DR.
    J Biol Response Mod; 1989 Dec 01; 8(6):593-602. PubMed ID: 2513378
    [Abstract] [Full Text] [Related]

  • 20. Role of positive charge of lysine residue on ribosome-inactivating property of gelonin.
    Singh RC, Alam A, Singh V.
    Indian J Biochem Biophys; 2001 Oct 01; 38(5):309-12. PubMed ID: 11886078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 391.